# Evolus, Inc. (EOLS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/EOLS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 157.22M | $ -18.73M | $ -14.00M | $ 164.80M | $ -30.90M |
| 2025 | $ 304.28M | $ -52.88M | $ -51.93M | $ 155.00M | $ -23.11M |
| 2024 | $ 279.88M | $ -53.00M | $ -23.99M | $ 129.98M | $ 5.52M |
| 2023 | $ 218.50M | $ -66.70M | $ -38.31M | $ 126.55M | $ -20.69M |
| 2022 | $ 166.02M | $ -83.13M | $ -98.14M | $ 74.42M | $ 18.50M |
| 2021 | $ 118.48M | $ -55.64M | $ -40.84M | $ 74.74M | $ 81.88M |
| 2020 | $ 72.03M | $ -207.67M | $ -77.36M | $ 138.32M | $ -72.96M |
| 2019 | $ 45.08M | $ -116.21M | $ -126.43M | $ 96.55M | $ 79.46M |
| 2018 | $ 0 | $ -61.90M | $ -33.92M | $ 16.90M | $ -123.03M |
| 2017 | $ 0 | $ -6.04M | $ -17.56M | $ 211.33M | $ -75.54M |
| 2016 | $ 0 | $ -27.61M | $ -18.25M | $ 59.76M | $ -7.11M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -5.33 |
| Liabilities / Eq | -9.03 |
| Current Ratio | 1.70 |

## Other views

- [Metrics](https://sponda.capital/en/EOLS.md)
- [Charts](https://sponda.capital/en/EOLS/charts.md)
- [Compare](https://sponda.capital/en/EOLS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.